AstraZeneca Global R&D (China) Co., Ltd.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Long-term Follow-up Study in Subjects With Multiple Myeloma Previously Treated With GC012F Injection	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Not yet recruiting	Not stated	2026-09-22		NCT07833046
GC012F Injection in Refractory Idiopathic Inflammatory Myopathy	muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease	Recruiting	Early phase 1	2026-01-14		NCT07086404

Clinical trials